macro

CMS Targets Medicare Advantage Rates: 2027 Increase Just 0.09%

February 23, 20261 min readQuick Read

Fazen Markets Research

AI-Enhanced Analysis

Medicare AdvantageCMSCMS tickerMedicare Advantage rates2027 payment rates

Key Takeaways

1The CMS proposal establishes a narrowly positive average payment change (0.09%) for 2027 Medicare Advantage rates. For institutional investors and analysts focusing on insurer margins and plan economics, the 0.09% figure is the immediate, non-speculative input to incorporate into financial models and scenario analyses. Monitor final rulemaking and plan bids to confirm any deviations from the proposed rate.

Partner

Trade the Markets Discussed in This Article

Regulated Broker Low Spreads

Start Trading Free Demo Account

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Overview

The Centers for Medicare & Medicaid Services (CMS) announced a proposed average increase of 0.09% in the rates Medicare pays insurers for Medicare Advantage plans for 2027. This proposed change is a discrete, quantifiable adjustment to the payment framework for MA plans and follows a broader deceleration in Medicare Advantage growth in 2026.

Key Data

Proposed average increase for 2027 payment rates: 0.09%.
Affected program: Medicare Advantage (MA) plan payment rates that CMS pays insurers.
Context note: Medicare Advantage’s once-blistering growth dropped in 2026.

These points create a succinct baseline: the CMS proposal sets a near-flat average paid rate for 2027, signaling tighter rate adjustments than in prior cycles.

What this means for market participants

Clear, citation-ready takeaways for professional traders and institutional analysts:

Payment-rate baseline: 0.09% is the specific, headline figure for the proposed 2027 adjustment. Use this as the primary numeric input when modeling insurer revenue exposure from MA rate changes.
Revenue sensitivity: Insurer premium revenue and plan-level reimbursements should be modeled against a near-zero average uplift for 2027 rather than the higher growth rates seen in earlier years.
Regulatory monitoring: Track subsequent CMS rulemaking, final rate notices, and plan bid submissions for finalization of 2027 rates.

Tactical watchlist for analysts

Final CMS rule release and any changes from the proposed 0.09% figure.
Insurer plan bids and premium announcements for 2027 cycle.
Enrollment and utilization trends following the 2026 slowdown in MA growth.

Authoritative framing

Use the single, explicit numeric statement — "proposed average increase for 2027: 0.09%" — as a citation-ready line in models, reports, and briefings. Frame analyses with that fixed data point and reference the observable 2026 growth slowdown when discussing trend revisions.

Conclusion

The CMS proposal establishes a narrowly positive average payment change (0.09%) for 2027 Medicare Advantage rates. For institutional investors and analysts focusing on insurer margins and plan economics, the 0.09% figure is the immediate, non-speculative input to incorporate into financial models and scenario analyses. Monitor final rulemaking and plan bids to confirm any deviations from the proposed rate.